Literature DB >> 21994902

mRNA and microRNA expression patterns in adrenocortical cancer.

Adrienn Zsippai1, Diana Rita Szabó, Peter M Szabó, Zsófia Tömböl, Melinda R Bendes, Zoltán Nagy, Károly Rácz, Peter Igaz.   

Abstract

Adrenocortical cancer is a rare tumor and its prognosis is poor. Although numerous tumor-associated genetic and signal transduction alterations have been described to date, its pathogenesis is still unclear. Hybridization-based DNA microarray approaches may reveal significant gene expression alterations and may thus contribute to a better understanding of tumorigenesis and may identify molecular markers applicable for the distinction of benign and malignant lesions. Beside gene expression patterns, studies on microRNAs seem to be useful, as well. Novel therapeutical targets might be established by these approaches. In this review, the authors attempt to summarize the main findings of mRNA and microRNA expression microarray studies performed to date in adrenocortical cancer including a recent meta-analysis of gene expression data and present novel pathogenic pathways.

Entities:  

Keywords:  Adrenocortical tumor; gene expression; meta-analysis; microRNA; microarray

Year:  2011        PMID: 21994902      PMCID: PMC3189823     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  45 in total

Review 1.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

2.  High expression of cyclin E and G1 CDK and loss of function of p57KIP2 are involved in proliferation of malignant sporadic adrenocortical tumors.

Authors:  N Bourcigaux; V Gaston; A Logié; X Bertagna; Y Le Bouc; C Gicquel
Journal:  J Clin Endocrinol Metab       Date:  2000-01       Impact factor: 5.958

3.  Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic Acid microarrays identifies several candidate genes as markers of malignancy.

Authors:  Florence de Fraipont; Michelle El Atifi; Nadia Cherradi; Gwennaelle Le Moigne; Geneviève Defaye; Rémi Houlgatte; Jérôme Bertherat; Xavier Bertagna; Pierre-François Plouin; Eric Baudin; François Berger; Christine Gicquel; Olivier Chabre; Jean-Jacques Feige
Journal:  J Clin Endocrinol Metab       Date:  2004-12-21       Impact factor: 5.958

4.  Differential expression and action of Toll-like receptors in human adrenocortical cells.

Authors:  Waldemar Kanczkowski; Kai Zacharowski; Manfred P Wirth; Monika Ehrhart-Bornstein; Stefan R Bornstein
Journal:  Mol Cell Endocrinol       Date:  2008-10-31       Impact factor: 4.102

Review 5.  Transcriptome analysis of adrenocortical cancers: from molecular classification to the identification of new treatments.

Authors:  Bruno Ragazzon; Guillaume Assié; Jérôme Bertherat
Journal:  Endocr Relat Cancer       Date:  2011-02-23       Impact factor: 5.678

6.  Prevalence of HLA-DRB1 genotype and altered Fas/Fas ligand expression in adrenocortical carcinoma.

Authors:  Gernot W Wolkersdörfer; Christian Marx; John Brown; Sabine Schröder; Monika Füssel; E Peter Rieber; Eberhard Kuhlisch; Gerhard Ehninger; Stefan R Bornstein
Journal:  J Clin Endocrinol Metab       Date:  2004-12-07       Impact factor: 5.958

7.  MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy.

Authors:  Erin E Patterson; Alisha K Holloway; Julie Weng; Tito Fojo; Electron Kebebew
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

8.  Topoisomerase IIalpha mRNA and protein expression in ovarian carcinoma: correlation with clinicopathological factors and prognosis.

Authors:  Areeg Faggad; Silvia Darb-Esfahani; Ralph Wirtz; Bruno Sinn; Jalid Sehouli; Dominique Könsgen; Hermann Lage; Wilko Weichert; Aurelia Noske; Jan Budczies; Berit M Müller; Ann-Christin Buckendahl; Annika Röske; Nasr Eldin Elwali; Manfred Dietel; Carsten Denkert
Journal:  Mod Pathol       Date:  2009-03-06       Impact factor: 7.842

Review 9.  Peroxisome proliferator-activated receptor gamma pathway targeting in carcinogenesis: implications for chemoprevention.

Authors:  Frank Ondrey
Journal:  Clin Cancer Res       Date:  2009-01-01       Impact factor: 12.531

Review 10.  Strategy and mechanism for the prevention of hepatocellular carcinoma: phosphorylated retinoid X receptor alpha is a critical target for hepatocellular carcinoma chemoprevention.

Authors:  Masahito Shimizu; Koji Takai; Hisataka Moriwaki
Journal:  Cancer Sci       Date:  2008-12-04       Impact factor: 6.716

View more
  8 in total

Review 1.  Minireview: miRomics in endocrinology: a novel approach for modeling endocrine diseases.

Authors:  Péter M Szabó; Henriett Butz; Péter Igaz; Károly Rácz; László Hunyady; Attila Patócs
Journal:  Mol Endocrinol       Date:  2013-01-24

Review 2.  Molecular markers of adrenocortical tumors.

Authors:  Meenu Jain; Nesrin Rechache; Electron Kebebew
Journal:  J Surg Oncol       Date:  2012-04-13       Impact factor: 3.454

Review 3.  The 'omics' of adrenocortical tumours for personalized medicine.

Authors:  Guillaume Assié; Anne Jouinot; Jérôme Bertherat
Journal:  Nat Rev Endocrinol       Date:  2014-02-04       Impact factor: 43.330

Review 4.  5th International ACC Symposium: Classification of Adrenocortical Cancers from Pathology to Integrated Genomics: Real Advances or Lost in Translation?

Authors:  Ronald E de Krijger; Jérôme Bertherat
Journal:  Horm Cancer       Date:  2015-12-16       Impact factor: 3.869

5.  Single nucleotide polymorphism array profiling of adrenocortical tumors--evidence for an adenoma carcinoma sequence?

Authors:  Cristina L Ronchi; Silviu Sbiera; Ellen Leich; Katharina Henzel; Andreas Rosenwald; Bruno Allolio; Martin Fassnacht
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

6.  Wnt/β-catenin activation cooperates with loss of p53 to cause adrenocortical carcinoma in mice.

Authors:  Kleiton Silva Borges; Emanuele Pignatti; Sining Leng; Dulanjalee Kariyawasam; Gerard Ruiz-Babot; Fernando Silva Ramalho; Makoto Mark Taketo; Diana L Carlone; David T Breault
Journal:  Oncogene       Date:  2020-06-19       Impact factor: 9.867

7.  Dual effects of 9-cis retinoic acid on ACTH-dependent hyperplastic adrenal tissues.

Authors:  Francesca Pecori Giraldi; Antonella Sesta; Laura Tapella; Maria Francesca Cassarino; Luigi Castelli
Journal:  Sci Rep       Date:  2021-07-12       Impact factor: 4.379

8.  Circulating microRNA Expression in Cushing's Syndrome.

Authors:  Sharmilee Vetrivel; Ru Zhang; Mareen Engel; Barbara Altieri; Leah Braun; Andrea Osswald; Martin Bidlingmaier; Martin Fassnacht; Felix Beuschlein; Martin Reincke; Alon Chen; Silviu Sbiera; Anna Riester
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-22       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.